
GLP1-RAs in Type 1 Diabetes: more than meets the eye?
Some people will be aware, and some not, that there is a reasonable minority of people with Type 1 Diabetes using GLP-1 Receptor Agonists (GLP1-RAs) […]
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Some people will be aware, and some not, that there is a reasonable minority of people with Type 1 Diabetes using GLP-1 Receptor Agonists (GLP1-RAs) […]
In all the noise around EASD, you may not have noticed that Microtech have launched a new CGM. This is their follow up to Aidex, […]
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
With performance numbers on the new 15-day, prescription free, Stelo sensor from Dexcom looking very similar to those from the G7, could Dexcom be contemplating the announcement of an uldated 15-day iCGM at EASD in Madrid?
There are regularly calls in the #WeAreNotWaiting world to incorporate exercise detection into the algorithms that we use, so that end users can minimise hypo […]
Ever since the Omnipod appeared, the question over what type of pump to use has been a constant question from both new users and those […]
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
It has probably passed most people by, but there were some very interesting statements from Ypsomed in regard to their Diabetes product line towards the […]
As I mentioned a couple of weeks ago, I received a number of Libre2 and Libre2 Plus devices to try. So far, I’ve only used […]
Copyright © 2025 | WordPress Theme by MH Themes